PRA Health Sciences (PRAH) Tops Q2 EPS by 3c, Revenues Beat: Offers FY20 EPS Outlook Above Consensus, FY20 Revenue Mid-Point View Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to PRA Health Sciences (PRAH) Tops Q2 EPS by 3c, Revenues Beat: Offers FY20 EPS Outlook Above Consensus, FY20 Revenue Mid-Point View Above Consensus

PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance

August 6, 2020 4:02 PM EDT

Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenue
Net new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million of total revenue; representing a decrease of 4.4% at actual foreign exchange rates and 3.8% on a constant currency basisGAAP net income per diluted share of $0.22; GAAP net income of $13.9 million Adjusted net income per diluted share was $0.86; Adjusted net income of $55.2 millionFull year 2020 revenue guidance between $3.07 billion and $3.13 billion, GAAP net income per diluted share between $2.40 and $2.60 and adjusted net... More